AESKULISA® 30-7215US β2-Glyco-Check - AESKU We take care of your health

Abbildung ähnlich

Referenz:

30-7215US

Bezeichnung:

β2-Glyco-Check

Verwendungszweck:

AESKULISA® ß2-Glyco-Check is a solid phase enzyme immunoassay employing native ß2 glycoprotein I highly purified from human plasma for the combined semiquantitative and qualitative detection of IgA, IgG and IgM antibodies against ß2 glycoprotein I in human serum. The presence of anti-ß2 glycoprotein I antibodies in conjunction with clinical findings and other laboratory results can be used as an aid in the diagnosis of thrombotic disorders related to primary and secondary antiphospholipid syndrome.

Methode:

ELISA

Konjugat:

IgA

,

IgG

,

IgM

Auswertung:

Qualitativ

,

Semi-quantitativ

Cut Off:

20 U/ml

Messbereich:

0-300 U/ml

Bestimmungen:

1 x 96

Kit-Konfiguration:

Single-Check

Anzahl Antigene:

1

Registrierung:

FDA-cleared

Beschichtete Antigene:

ß2-Glykoprotein I

AESKULISA®

30-7215US

β2-Glyco-Check

Abbildung ähnlich

Verwendungszweck:

AESKULISA® ß2-Glyco-Check is a solid phase enzyme immunoassay employing native ß2 glycoprotein I highly purified from human plasma for the combined semiquantitative and qualitative detection of IgA, IgG and IgM antibodies against ß2 glycoprotein I in human serum. The presence of anti-ß2 glycoprotein I antibodies in conjunction with clinical findings and other laboratory results can be used as an aid in the diagnosis of thrombotic disorders related to primary and secondary antiphospholipid syndrome.

Methode:

ELISA

Konjugat:

IgA

,

IgG

,

IgM

Auswertung:

Qualitativ

,

Semi-quantitativ